Brca1-Associated Proteins: Novel Targets For Breast Cancer Radiation Therapy

Xiaowei Chen,Jamie L. Kistler,Andrew K. Godwin

2010-01-01

Abstract:Tumor cells, in general, are genomically unstable and have defects in DNA repair pathways, which subsequently hinder DNA damage responses. It has been proposed that therapeutic strategies specifically targeting DNA repair pathway proteins may lead to an increased therapeutic index in tumor cells versus normal cells. The BRCA1 pathways are known to play a critical role in DNA repair; thus, breast tumors with defects in proteins associated with the BRCA1 pathways are believed to be more sensitive to DNA damage-based therapies. BRCA1 can interact directly or indirectly with other tumor suppressors, DNA damage sensors, ubiquitin ligase partners, and signal transducers to form multi-subunit protein complexes. These protein complexes are involved in a broad range of biological processes including DNA repair, cell cycle control, ubiquitination, and chromatin remodeling. Growing evidence suggests that mutation and/or aberrant expression of one or more key members of the BRCA1-associated multi-protein complexes may result in loss of normal BRCA1 activity and disruption of the BRCA1 pathways. These BRCA1-associated proteins are potential modifiers of BRCA1 functions and, therefore, potential targets for sensitizing breast cancer cells to radiation therapy.